CD4 and breast cancer: However, compared to NCs, the absolute counts (AC) of CD3+(929.03 ± 241.42 vs. 1680.24 ± 549.30), CD4+(442.58 ± 97.05 vs. 933.60 ± 340.92), CD8+ (321.49 ± 112.56 vs. 647.42 ± 280.40), B (178.44 ± 80.43 vs. 283.35 ± 157.74), and NK (174.54 ± 71.44 vs. 400.04 ± 162.08) cells were decreased significantly in BC patients (P < 0.001) (Figure 1(b)).